Bo Dupont - Publications

Affiliations: 
Memorial Sloan Kettering Cancer Center, Rockville Centre, NY, United States 
Area:
Immunology
Website:
https://www.the-asci.org/controllers/asci/AsciProfileController.php?pid=154335

85 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Boudreau JE, Liu XR, Zhao Z, Zhang A, Shultz LD, Greiner DL, Dupont B, Hsu KC. Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I. Immunity. PMID 27496730 DOI: 10.1016/j.immuni.2016.07.005  0.4
2016 Hasan AN, Selvakumar A, Shabrova E, Liu XR, Afridi F, Heller G, Riviere I, Sadelain M, Dupont B, O'Reilly RJ. Soluble and membrane bound IL-15 Rα/IL-15 complexes mediate proliferation of high avidity central memory CD8(+) T-cells for adoptive immunotherapy of cancer and infections. Clinical and Experimental Immunology. PMID 27227483 DOI: 10.1111/cei.12816  0.52
2014 Venstrom JM, Dupont B, Hsu KC, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E. Donor activating KIR2DS1 in leukemia. The New England Journal of Medicine. 371: 2042. PMID 25409391 DOI: 10.1056/NEJMc1411443  0.32
2013 Pittari G, Liu XR, Selvakumar A, Zhao Z, Merino E, Huse M, Chewning JH, Hsu KC, Dupont B. NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand. Journal of Immunology (Baltimore, Md. : 1950). 190: 4650-60. PMID 23554313 DOI: 10.4049/jimmunol.1202120  0.4
2012 Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC. HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. The New England Journal of Medicine. 367: 805-16. PMID 22931314 DOI: 10.1056/NEJMoa1200503  0.32
2012 Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC. Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment. The Journal of Clinical Investigation. 122: 3260-70. PMID 22863621 DOI: 10.1172/JCI62749  0.4
2012 Jelcić I, Hsu KC, Kakalacheva K, Breiden P, Dupont B, Uhrberg M, Martin R, Münz C, Lünemann JD. Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 951-8. PMID 22185807 DOI: 10.1177/1352458511431726  0.32
2010 Venstrom JM, Gooley TA, Spellman S, Pring J, Malkki M, Dupont B, Petersdorf E, Hsu KC. Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood. 115: 3162-5. PMID 20124216 DOI: 10.1182/blood-2009-08-236943  0.32
2009 Venstrom JM, Zheng J, Noor N, Danis KE, Yeh AW, Cheung IY, Dupont B, O'Reilly RJ, Cheung NK, Hsu KC. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7330-4. PMID 19934297 DOI: 10.1158/1078-0432.CCR-09-1720  1
2009 Hasan AN, Kollen WJ, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly RJ. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy. Journal of Immunology (Baltimore, Md. : 1950). 183: 2837-50. PMID 19635907 DOI: 10.4049/jimmunol.0804178  1
2009 Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4467-74. PMID 19531622 DOI: 10.1158/1078-0432.CCR-09-0582  1
2009 Bioley G, Guillaume P, Luescher I, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Valmori D, Ayyoub M. HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 299-306. PMID 19118058 DOI: 10.1158/1078-0432.CCR-08-1747  1
2008 Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD, Barlogie B, van Rhee F. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. British Journal of Haematology. 143: 641-53. PMID 18950462 DOI: 10.1111/j.1365-2141.2008.07340.x  0.32
2008 Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, Mohanakumar T, Hsu KC, Dupont B, Yokoyama WM. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proceedings of the National Academy of Sciences of the United States of America. 105: 3053-8. PMID 18287063 DOI: 10.1073/pnas.0712229105  0.32
2007 Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. Journal of Immunology (Baltimore, Md. : 1950). 179: 854-68. PMID 17617576  0.4
2006 Farag SS, Bacigalupo A, Eapen M, Hurley C, Dupont B, Caligiuri MA, Boudreau C, Nelson G, Oudshoorn M, van Rood J, Velardi A, Maiers M, Setterholm M, Confer D, Posch PE, et al. The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry Biology of Blood and Marrow Transplantation. 12: 876-884. PMID 16864058 DOI: 10.1016/j.bbmt.2006.05.007  1
2006 Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 828-36. PMID 16864053 DOI: 10.1016/j.bbmt.2006.04.008  1
2005 Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, et al. Nomenclature for Factors of the HLA System, 2004. Human Immunology. 66: 571-636. PMID 15935895 DOI: 10.1016/j.humimm.2005.02.002  1
2005 Hsu KC, Dupont B. Natural killer cell receptors: regulating innate immune responses to hematologic malignancy. Seminars in Hematology. 42: 91-103. PMID 15846575  0.32
2005 Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood. 105: 4878-84. PMID 15731175 DOI: 10.1182/blood-2004-12-4825  0.52
2005 Huang W, Ochs HD, Dupont B, Vyas YM. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. Journal of Immunology (Baltimore, Md. : 1950). 174: 2602-11. PMID 15728466  0.52
2004 Dupont B, Hsu KC. Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation. Current Opinion in Immunology. 16: 634-43. PMID 15342011 DOI: 10.1016/j.coi.2004.07.013  0.32
2004 Vyas YM, Maniar H, Lyddane CE, Sadelain M, Dupont B. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals Journal of Immunology. 173: 1571-1578. PMID 15265884  1
2004 Atanackovic D, Altorki NK, Stockert E, Williamson B, Jungbluth AA, Ritter E, Santiago D, Ferrara CA, Matsuo M, Selvakumar A, Dupont B, Chen YT, Hoffman EW, Ritter G, Old LJ, et al. Vaccine-induced CD4+ T cell responses to MAGE-3 protein in lung cancer patients. Journal of Immunology (Baltimore, Md. : 1950). 172: 3289-96. PMID 14978137  0.4
2003 Doubrovina ES, Doubrovin MM, Vider E, Sisson RB, O'Reilly RJ, Dupont B, Vyas YM. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950). 171: 6891-9. PMID 14662896  0.52
2003 Zhang L, Hsu KC, Liu XR, Yang JQ, Yao FJ, Xu LD, Dupont B, Fan LA. [Killer Ig-like receptor gene content diversity and haplotype analysis in Chinese Han population in Shanghai]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics. 20: 396-9. PMID 14556191  0.4
2003 Gnjatic S, Atanackovic D, Jäger E, Matsuo M, Selvakumar A, Altorki NK, Maki RG, Dupont B, Ritter G, Chen YT, Knuth A, Old LJ. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. Proceedings of the National Academy of Sciences of the United States of America. 100: 8862-7. PMID 12853579 DOI: 10.1073/pnas.1133324100  0.4
2003 Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics. 55: 220-6. PMID 12838378 DOI: 10.1007/s00251-003-0571-z  0.32
2003 Marsh SG, Parham P, Dupont B, Geraghty DE, Trowsdale J, Middleton D, Vilches C, Carrington M, Witt C, Guethlein LA, Shilling H, Garcia CA, Hsu KC, Wain H. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Human Immunology. 64: 648-54. PMID 12770798 DOI: 10.1016/S0198-8859(03)00067-3  0.32
2002 Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunological Reviews. 190: 40-52. PMID 12493005  0.32
2002 Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 2002. Human Immunology. 63: 1213-68. PMID 12480266 DOI: 10.1016/S0198-8859(02)00769-3  1
2002 Vyas YM, Maniar H, Dupont B. Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses. Immunological Reviews. 189: 161-78. PMID 12445273  0.52
2002 Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, et al. Nomenclature for factors of the HLA system, 2002. European Journal of Immunogenetics : Official Journal of the British Society For Histocompatibility and Immunogenetics. 29: 463-515. PMID 12437610 DOI: 10.1046/j.1365-2370.2002.00359.x  1
2002 Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. Journal of Immunology (Baltimore, Md. : 1950). 169: 5118-29. PMID 12391228  0.52
2002 Vyas YM, Maniar H, Dupont B. Cutting edge: differential segregation of the SRC homology 2-containing protein tyrosine phosphatase-1 within the early NK cell immune synapse distinguishes noncytolytic from cytolytic interactions. Journal of Immunology (Baltimore, Md. : 1950). 168: 3150-4. PMID 11907066  0.52
2002 Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG, Dupont B, O'Reilly RJ. Quantitation, selection, and functional characterization of Epstein-Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood. 99: 1730-40. PMID 11861290 DOI: 10.1182/blood.V99.5.1730  1
2001 Vyas YM, Mehta KM, Morgan M, Maniar H, Butros L, Jung S, Burkhardt JK, Dupont B. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions Journal of Immunology. 167: 4358-4367. PMID 11591760  1
2001 Marti F, Krause A, Post NH, Lyddane C, Dupont B, Sadelain M, King PD. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6 Journal of Immunology. 166: 197-206. PMID 11123293 DOI: 10.4049/jimmunol.166.1.197  1
2000 Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ. Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proceedings of the National Academy of Sciences of the United States of America. 97: 10917-22. PMID 11005863 DOI: 10.1073/PNAS.97.20.10917  1
1998 Connelly RJ, Hayden MS, Scholler JK, Tsu TT, Dupont B, Ledbetter JA, Kanner SB. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes. International Immunology. 10: 1863-72. PMID 9885907 DOI: 10.1093/INTIMM/10.12.1863  1
1998 King PD, Sadra A, Teng JM, Bell GM, Dupont B. CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. International Immunology. 10: 1009-16. PMID 9701039 DOI: 10.1093/INTIMM/10.7.1009  0.48
1997 August A, Sadra A, Dupont B, Hanafusa H. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proceedings of the National Academy of Sciences of the United States of America. 94: 11227-32. PMID 9326591 DOI: 10.1073/pnas.94.21.11227  1
1996 Gibson S, August A, Branch D, Dupont B, Mills GB. Functional LCK is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK Journal of Biological Chemistry. 271: 7079-7083. PMID 8636141 DOI: 10.1074/jbc.271.12.7079  1
1996 August A, Dupont B. Association between mitogen-activated protein kinase and the ζ chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck: Differential regulation by TcR cross-linking Journal of Biological Chemistry. 271: 10054-10059. PMID 8626561 DOI: 10.1074/jbc.271.17.10054  1
1995 August A, Dupont B. Activation of extracellular signal-regulated protein kinase (ERK/MAP kinase) following CD28 cross-linking: Activation in cells lacking p56(lck) Tissue Antigens. 46: 155-162. PMID 8525474 DOI: 10.1111/j.1399-0039.1995.tb03114.x  1
1994 August A, Dupont B. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line Biochemical and Biophysical Research Communications. 199: 1466-1473. PMID 8147892 DOI: 10.1006/bbrc.1994.1396  1
1994 August A, Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase International Immunology. 6: 769-774. PMID 8080844 DOI: 10.1093/intimm/6.5.769  1
1992 Geisberg M, Terry LA, Flomenberg N, Dupont B. Cytotoxic and proliferative allospecific T-cell clones contain perforin and mediate anti-CD3-induced cytotoxicity Human Immunology. 35: 239-245. PMID 1293087 DOI: 10.1016/0198-8859(92)90005-8  1
1991 Koulova L, Clark EA, Shu G, Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells Journal of Experimental Medicine. 173: 759-762. PMID 1847724 DOI: 10.1084/JEM.173.3.759  1
1990 Hämmerling GJ, Chamberlain JW, Dill O, Yang SY, Dupont B, Khan R, Chua R, Weissman SM, Hämmerling U. Self-tolerance to HLA focuses the response of immunized HLA-transgenic mice on production of antibody to precise polymorphic HLA alloantigens. Proceedings of the National Academy of Sciences of the United States of America. 87: 235-9. PMID 2404277 DOI: 10.1073/pnas.87.1.235  1
1990 Klein JL, Selvakumar A, Trapani JA, Dupont B. Characterization of a novel, human cytotoxic lymphocyte-specific serine protease cDNA clone (CSP-C) Tissue Antigens. 35: 220-228. PMID 2402757 DOI: 10.1111/J.1399-0039.1990.TB01787.X  1
1990 Rosenkrantz K, Bhimani K, Welte K, Buck J, DiSanto J, Levi E, DiMartino J, Hammerling U, Dupont B, Flomenberg N. A novel autoregulatory cytokine is required for the regulation of autoaggressive responses. Human Immunology. 27: 254-64. PMID 2187837 DOI: 10.1016/0198-8859(90)90055-T  0.44
1989 Klein JL, Shows TB, Dupont B, Trapani JA. Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes Genomics. 5: 110-117. PMID 2788607 DOI: 10.1016/0888-7543(89)90093-1  1
1989 Small TN, Keever C, Collins N, Dupont B, O'Reilly RJ, Flomenberg N. Characterization of B cells in severe combined immunodeficiency disease. Human Immunology. 25: 181-93. PMID 2670851 DOI: 10.1016/0198-8859(89)90081-5  1
1989 Keever CA, Flomenberg N, Small T, Brochstein J, Collins N, Young-Yang S, Insel R, Dupont B, O'Reilly RJ. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease. Human Immunology. 26: 27-38. PMID 2528525 DOI: 10.1016/0198-8859(89)90030-X  1
1988 Trapani JA, Klein JL, White PC, Dupont B. Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes Proceedings of the National Academy of Sciences of the United States of America. 85: 6924-6928. PMID 3261871 DOI: 10.1073/pnas.85.18.6924  1
1988 Keever CA, Flomenberg N, Brochstein J, Sullivan M, Collins NH, Burns J, Dupont B, O'Reilly RJ. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency. Clinical Immunology and Immunopathology. 48: 261-76. PMID 3042210 DOI: 10.1016/0090-1229(88)90020-7  1
1986 O'Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Kernan N, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sanguinis. 51: 81-6. PMID 3532540 DOI: 10.1111/j.1423-0410.1986.tb02013.x  1
1985 Broxmeyer HE, Dupont B. A role for class-II major histocompatibility complex antigens in the regulation of myelopoiesis Progress in Allergy. 36: 203-221. PMID 2578673  1
1983 Mandel FP, Chang RJ, Dupont B, Pollack MS, Levine LS, New MI, Lu JK, Judd HL. HLA genotyping in family members and patients with familial polycystic ovarian disease. The Journal of Clinical Endocrinology and Metabolism. 56: 862-4. PMID 6833465 DOI: 10.1210/jcem-56-4-862  1
1983 Pollack MS, da Silva BM, Moshief RD, Groshen S, Bognacki J, Dupont B, de Sousa M. Ferritin secretion by human mononuclear cells: association with HLA phenotype. Clinical Immunology and Immunopathology. 27: 124-34. PMID 6347485 DOI: 10.1016/0090-1229(83)90061-2  1
1983 New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. The Journal of Clinical Endocrinology and Metabolism. 57: 320-6. PMID 6306039 DOI: 10.1210/jcem-57-2-320  1
1983 Pang S, Levine LS, Stoner E, Opitz JM, Pollack MS, Dupont B, New MI. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function. The Journal of Clinical Endocrinology and Metabolism. 56: 808-18. PMID 6300166 DOI: 10.1210/jcem-56-4-808  1
1982 O'Neill GJ, Dupont B, Pollack MS, Levine LS, New MI. Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. Clinical Immunology and Immunopathology. 23: 312-22. PMID 6980755 DOI: 10.1016/0090-1229(82)90117-9  1
1982 Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 55: 817-27. PMID 6288753 DOI: 10.1210/jcem-55-5-817  1
1981 Brautbar C, Theodor R, Sack J, Levene C, Dupont B, Levine LS, Sharon R, Smaller S, Cohen T, Rösler A. HLA in a selective aldosterone biosynthetic defect due to type 2 corticosterone methyl-oxidase deficiency. Tissue Antigens. 17: 212-6. PMID 7233416 DOI: 10.1111/J.1399-0039.1981.TB00685.X  1
1981 New MI, Dupont B, Pang S, Pollack M, Levine LS. An update of congenital adrenal hyperplasia. Recent Progress in Hormone Research. 37: 105-81. PMID 7025132 DOI: 10.1016/B978-0-12-571137-1.50008-6  1
1981 New MI, Dupont B, Pollack MS, Levine LS. The biochemical basis for genotyping 21-hydroxylase deficiency. Human Genetics. 58: 123-7. PMID 6269988 DOI: 10.1007/BF00284159  1
1980 Cunningham-Rundles S, Cunningham-Rundles C, Dupont B, Good RA. Zinc-induced activation of human B lymphocytes. Clinical Immunology and Immunopathology. 16: 115-22. PMID 6991178 DOI: 10.1016/0090-1229(80)90172-5  0.32
1980 Pollack MS, Livingston PO, Fogh J, Carey TE, Oettgen HF, Dupont B. Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines. Tissue Antigens. 15: 249-56. PMID 6451045 DOI: 10.1111/J.1399-0039.1980.TB00915.X  1
1980 Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver DM, Dupont B, O'Reilly RJ. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation. 30: 331-4. PMID 6450472 DOI: 10.1097/00007890-198011000-00004  0.52
1980 Laron Z, Pollack MS, Zamir R, Roitman A, Dickerman Z, Levine LS, Lorenzen F, O'Neill GJ, Pang S, New MI, Dupont B. Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Human Immunology. 1: 55-66. PMID 6266983 DOI: 10.1016/0198-8859(80)90009-9  1
1980 Pang S, Levine LS, Lorenzen F, Chow D, Pollack M, Dupont B, Genel M, New MI. Hormonal studies in obligate heterozygotes and siblings of patients with 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 50: 586-9. PMID 6244328 DOI: 10.1210/jcem-50-3-586  1
1979 Willoughby EW, Dupont B, Good RA. Prostaglandin effect on lymphokine production in multiple sclerosis. Annals of Neurology. 5: 391-3. PMID 375809 DOI: 10.1002/ana.410050415  0.52
1979 Lorenzen F, Pang S, New MI, Dupont B, Pollack M, Chow DM, Levine LS. Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency). Pediatric Research. 13: 1356-60. PMID 230448 DOI: 10.1203/00006450-197912000-00011  1
1979 New MI, Lorenzen F, Pang S, Gunczler P, Dupont B, Levine LS. "Acquired" adrenal hyperplasia with 21-hydroxylase deficiency is not the same genetic disorders as congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 48: 356-9. PMID 218988 DOI: 10.1210/jcem-48-2-356  1
1979 Duquesnoy RJ, Marrari M, Annen K, Pollack MS, Dupont B. HLA-DR antigens in Black North-Americans and their association with HLA-D Tissue Antigens. 14: 145-156. PMID 91224 DOI: 10.1111/J.1399-0039.1979.TB00832.X  1
1978 Levine LS, Zachmann M, New MI, Prader A, Pollack MS, O'Neill GJ, Yang SY, Oberfield SE, Dupont B. Genetic mapping of the 21-hydroxylase-deficiency gene within the HLA linkage group. The New England Journal of Medicine. 299: 911-5. PMID 692595 DOI: 10.1056/NEJM197810262991702  1
1978 Willoughby EW, Dupont B, Hansen JA, Good RA. The indirect assay for leukocyte migration inhibitory factor (LIF) - Standardization and the effect of pH Journal of Immunological Methods. 22: 99-110. PMID 27562 DOI: 10.1016/0022-1759(78)90062-5  1
1977 Dupont B, Oberfield SE, Smithwick EM, Lee TD, Levine LS. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency). Lancet. 2: 1309-12. PMID 74726 DOI: 10.1016/S0140-6736(77)90362-2  1
1977 Hansen JA, Good RA, Dupont B. HLA-D compatibility between parent and child: Increased occurrence in severe combined immunodeficiency and other hematopoietic diseases Transplantation. 23: 366-374. PMID 17183 DOI: 10.1097/00007890-197704000-00011  1
1976 Thompson JS, Braun WE, Carpenter CB, Dossetor JB, Dupont B, Falk JA, Ferrone S, Johnson AH, Shaw JF, Singal DP, Terasaki TI, Troup GM, Walford RL. Summary report on the second New World B-cell workshop. Tissue Antigens. 8: 355-7. PMID 65026 DOI: 10.1111/j.1399-0039.1976.tb00587.x  1
1976 DuPont B, Hansen JA. Human mixed-lymphocyte culture reaction: genetics, specificity, and biological implications Advances in Immunology. 23: 107-202. PMID 63234 DOI: 10.1016/S0065-2776(08)60320-X  1
1975 Gorski AJ, Dupont B, Hansen JA, Good RA. Leukocyte migration inhibitory factor (LMIF) induced by concanavalin A: standardized microassay for production in vitro Proceedings of the National Academy of Sciences of the United States of America. 72: 3197-3200. PMID 1103141 DOI: 10.1073/pnas.72.8.3197  1
1975 Fu SM, Stern R, Kunkel HG, Dupont B, Hansen JA, Day NK, Good RA, Jersild C, Fotino M. Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families. The Journal of Experimental Medicine. 142: 495-506. PMID 124762 DOI: 10.1084/jem.142.2.495  1
Show low-probability matches.